Abbott Laboratories ABT recently received FDA approval for its Eterna spinal cord stimulation (SCS) system for treating chronic pain. The Eterna SCS system is the smallest implantable, rechargeable ...

Abbott ABT recently announced the first usage of its Eterna spinal cord stimulator (SCS) system in Canada. This marks a significant milestone in the company’s approach to chronic pain management. The ...

The U.S. Food and Drug Administration (FDA) approved Abbott (ABT)'s Eterna™ spinal cord stimulation (SCS) system for the treatment of chronic pain This neuromodulation device provides an optimized ...

Please provide your email address to receive an email when new articles are posted on . Expanded labeling allows those with chronic pain to have a wider selection of leads for full-body scans. Eterna ...

Abbott Laboratories (NYSE:ABT) announced Thursday that the FDA approved expanded MRI labeling for its pain relief device Eterna spinal cord stimulation (SCS) system, allowing its use in patients who ...

Building on the U.S. FDA approval of its Proclaim Plus spinal cord stimulation (SCS) system in August, Abbott Laboratories notched another approval with the FDA’s greenlight of the Eterna spinal cord ...

Abbott Park, Illinois Tuesday, January 27, 2026, 13:00 Hrs [IST] ...

Credit: Shutterstock. Study participants suffered from chronic back pain for an average of 12.8 years. The Food and Drug Administration (FDA) has expanded the approval of Abbott’s spinal cord ...

Abbott developed Eterna based on extensive studies with patients, physicians and caregivers to understand the unmet needs of people living with chronic pain. The studies found that people wanted a ...